Book Excerpt

​

A few years before his planned retirement as a commercial pilot, Peter Bartelli was shocked to hear that he’d failed a stress test due to blockage in his artery. He faced losing the passion of his life, flying, and a good chunk of his pension. Like millions who’d had their careers cut short by heart disease, he was devastated.

​   However, his life took a different turn than with most heart patients when his new cardiologist surprisingly recommended another approach; instead of just putting in another stent then having more heart drugs, he could change his diet and try a  nutraceutical compound designed to dissolve remaining blockages and keep the stent open. It was developed by a bio-pharmaceuticals startup created by maverick emergency room specialist Gary Mezo.

​   For a cardiologist who was also an executive with the American Heart Association, this was definitely pushing the envelope. However, this doctor was facing up to one troubling reality. He knew that cardiologists had never cured cardiovascular disease. They only slowed its progress or made it more tolerable. He was tired of that slow death-watch. So, he recommended, and Peter Bartelli agreed, to try this new approach.

​   According to Peter, several months later he passed his stress tests with flying colors. A heart catheterization showed no significant blockages and a wide open stent. The doctor who examined him was reportedly astonished and had him do other tests just to check. As a result, Peter regained his job, pension, and life. He enjoyed ten more years of flying that he otherwise might have missed. His cardiologist published in a peer-reviewed journal the results of a small ‘open label’ clinical study showing that other patients were improving.

​     Bartelli and his cardiologist aren't alone. Many other physicians and patients reported similar results using this approach. Others including at Cleveland Clinic published results showing reversal of conditions like prostate stones, where nothing else had worked.

​

You Can't Argue with A Saved Foot!

​

   A few years after Peter Bartelli improved, a deadlier drama was unfolding at Mt. Sinai Medical Center in Miami, Florida. A patient of Dr. Gervasio Lamas, Mt. Sinai’s and Columbia University’s head of cardiology, faced losing part of a leg to an insidious form of heart disease known as Critical Limb Ischemia, where a blocked blood supply slowly kills the leg and the patient. Due to this, hundreds of thousands of patients globally have their limbs cut off, and a quarter of patients die within a year of amputation. Millions of others endure painful surgeries to replace blocked arteries with vessels from other parts of their bodies.

   Lamas had run a clinical trial sponsored by the U.S. National Institutes of Health (NIH) to determine if a  detoxifying agent would help heart attack patients. It had. As a result, he decided to try the same approach with his amputation candidate. Her toes had black lesions. There was no record in medical history of reversing those at such a late stage. Surprisingly, Lamas had started the studies more than a decade earlier because he was convinced that they wouldn’t work. He and other skeptics of this widely used practice wanted to put it out of business for good. What they got instead was a surprise that shocked the cardiovascular world. The therapy was effective. With that knowledge in hand, Lamas decided that treating this patient was worth the risk.

   After forty weeks of regular infusions, the photographs spoke for themselves. The lesions were gone, and the patient was walking on a foot still attached to the leg. No amputation. X-rays showed that circulation had been restored. As with Peter Bartelli, this showed beyond a doubt that reversing the damage in heart disease with detoxifying substances was possible. Millions of patients might no longer have to suffer the life-threatening agony of amputation for this disease… at least that’s what Lamas hoped when he saw the results.

   Equally surprising was the amount of poisonous metals coming out in urine samples of patients during therapy. They’d never been near a metal mine in their lives, but still they had high levels of aluminum, cadmium, gadolinium, lead, lithium, nickel, tin, and other metals. Most troubling was that the standard medical lab tests didn’t show those levels prior to treatment.

​

​